My research interests focus on the roles mitochondria play in aspects of eukaryotic life, ranging from their origin, metabolism, biogenesis and role they play in cell death pathways. These are interrogated using biochemical, molecular biology, genetic and cell biology techniques. I incorporate these interests into classes I teach to provide an understanding of practical techniques and also the current literature in the field. I studied biochemistry at the University of Leeds, with an industrial placement at Astra Charnwood, followed by a PhD at the University of Bristol, supervised by Professor Andrew Halestrap, to characterise the molecular composition of the mitochondrial permeability transition pore, with support from MitoKor. My post-doctoral training on the mitochondrial pathway of apoptosis supervised by Dr Doug Green was at the La Jolla Institute of Allergy and Immunology in San Diego, California and St Jude Children's Research Hospital in Memphis, Tennessee. I then was an associate research scientist working in the laboratory of Professor Alexander Tzagoloff at Columbia University in New York to study biogenesis of mitochondrial cytochrome c oxidase in budding yeast, Saccharomyces cerevisiae. I held independent positions as assistant professor at the New York Institute of Technology in New York and Staffordshire University in Stoke-on-Trent where I continued my research and taught subjects related to biochemistry, cell biology, genetics and molecular biology. I am now a senior lecturer in biotechnology at Liverpool John Moores University.  I am a strong supporter of scientific communications and outreach to disseminate scientific developments and knowledge to a broader audience with the goal of increasing the general support of the scientific process. I also direct Biomed News, a free biomedical research literature discovery platform that uses machine learning.

I'm a PhD student currently studying aging with repurposed drugs. My model organism of interest is C. elegans.   I am deep-diving into topics of proteostasis, aging and drug repurposing.  Connect with me to explore more of these topics. 

Dr. Fun Man Fung is a trained Analytical Chemist. He earned his postgraduate degrees from NUS and Technische Universität München (TUM). As a passionate educator and aspiring change-maker, he has contributed articles for CNA Channel News Asia, The Straits Times, The Conversation, and the World Economic Forum. His research centers on STEAM Education, EdTech, Science of Learning, and 21st Century Skills. He co-edited two books on Chemistry Education: [1] 10 Things You Must Know About the International Chemistry Olympiad (World Scientific) and [2] Technology-Enabled Blended Learning Experiences for Chemistry Education and Outreach (Elsevier). In 2022, Fun Man was elected council member of the Singapore National Institute of Chemistry (SNIC), and he served on the IUPAC Committee on Chemistry Education since 2020. Since 2021, Fun Man served as a member of the Editorial Advisory Board at the Journal of Chemical Education, ACS Publications, and FEBS Open Bio, the premium Open-Access journal at the Federation of the European Biochemical Societies. He is the founding chair of the ACS International Chemical Sciences Chapter Singapore.

I hold a BSc in Biochemistry and an MSc in Medical Biochemistry, followed by a PhD in Medical Biology and Genetics. My research focuses on tumor heterogeneity and drug resistance. I am currently an Assistant Professor at the Faculty of Medicine, Istinye University.

Hello everyone, am I studying Molecular Medicine in Freiburg and work at  a biochemistry laboratory. The lab focuses on protein structure and protein interactions with one another. The lab project I am currently enrolled in aims on understanding one specific interaction of a scaffold protein with an urat transporter, because mutations in this protein have shown an increased urat concentration in the blood which results in a lower risk of getting gout.  I am always eager to learn more about other lab projects and newest breakthrough in biomedicine.

Biotechnologist with a strong commitment to research and innovation. Completed an esteemed MSc in Biotechnology at IST with a notable grade of 19/20, coupled with research experiences at TUM, Munich, and ITQB, Oeiras. Also hold a BSc in Biochemistry from FCUL with a commendable grade of 17/20. Previous industry exposure at Johnson & Johnson has reinforced dedication to advancing biotechnology for a healthier world. Currently pursuing a PhD at Gulbenkian Institute of Molecular Medicine at FMUL, focusing on developing targeted cancer therapies. Research involves bioinformatics-driven drug design to target receptors overexpressed in cancer cells, alongside the development and testing of patient-derived spheroids. Dedicated to contributing to a future where diseases are overcome through innovative approaches.